PR

PSP Research Portfolio holdings

AUM $141M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$141M
AUM Growth
+$26.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
105
New
Increased
Reduced
Closed

Top Buys

1
+$35.6M
2
+$6.17M
3
+$555K
4
GLUE icon
Monte Rosa Therapeutics
GLUE
+$535K
5
ARDX icon
Ardelyx
ARDX
+$529K

Top Sells

1
+$584K
2
+$554K
3
+$552K
4
BLTE
Belite Bio
BLTE
+$551K
5
APLS
Apellis Pharmaceuticals
APLS
+$549K

Sector Composition

1 Healthcare 24.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARGX icon
26
argenx
ARGX
$51B
$468K 0.33%
641
+11
SNDX icon
27
Syndax Pharmaceuticals
SNDX
$1.74B
$467K 0.33%
20,000
-4,716
INBX icon
28
Inhibrx
INBX
$1.51B
$466K 0.33%
6,927
+538
ARQT icon
29
Arcutis Biotherapeutics
ARQT
$2.65B
$464K 0.33%
19,700
+984
RARE icon
30
Ultragenyx Pharmaceutical
RARE
$2.3B
$463K 0.33%
+22,100
MIRM icon
31
Mirum Pharmaceuticals
MIRM
$5.94B
$462K 0.33%
5,000
-1,854
COGT icon
32
Cogent Biosciences
COGT
$5.9B
$462K 0.33%
12,000
-1,233
GLUE icon
33
Monte Rosa Therapeutics
GLUE
$1.62B
$461K 0.33%
+28,000
IMCR icon
34
Immunocore
IMCR
$1.45B
$457K 0.32%
15,141
+717
CRSP icon
35
CRISPR Therapeutics
CRSP
$5.16B
$452K 0.32%
9,500
-80
BBIO icon
36
BridgeBio Pharma
BBIO
$13B
$446K 0.32%
6,000
-1,140
NRIX icon
37
Nurix Therapeutics
NRIX
$1.81B
$445K 0.31%
28,700
-13
AUPH icon
38
Aurinia Pharmaceuticals
AUPH
$2B
$445K 0.31%
30,000
-3,953
ACAD icon
39
Acadia Pharmaceuticals
ACAD
$3.63B
$440K 0.31%
19,766
RAPP
40
Rapport Therapeutics
RAPP
$1.89B
$438K 0.31%
14,000
-3,506
IMNM icon
41
Immunome
IMNM
$2.5B
$437K 0.31%
20,000
-5,245
KNSA icon
42
Kiniksa Pharmaceuticals
KNSA
$3.99B
$433K 0.31%
9,000
-3,655
TGTX icon
43
TG Therapeutics
TGTX
$6B
$432K 0.31%
13,000
-4,807
DNTH icon
44
Dianthus Therapeutics
DNTH
$4.74B
$420K 0.3%
5,000
-7,725
CLDX icon
45
Celldex Therapeutics
CLDX
$2.48B
$412K 0.29%
13,000
-7,368
PTCT icon
46
PTC Therapeutics
PTCT
$5.86B
$409K 0.29%
6,000
-1,046
VERA icon
47
Vera Therapeutics
VERA
$2.46B
$402K 0.28%
10,000
+4
HRMY icon
48
Harmony Biosciences
HRMY
$1.78B
$400K 0.28%
14,283
CRNX icon
49
Crinetics Pharmaceuticals
CRNX
$3.88B
$400K 0.28%
11,000
-316
CMPS
50
Compass Pathways
CMPS
$1.6B
$393K 0.28%
+71,000
1
2
3 4 5